Results 1 to 10 of about 95,409 (162)
Vaccines, 2016 Viral hepatitis is a serious health problem all over the world. However, the reduction of the morbidity and mortality due to vaccinations against hepatitis A and hepatitis B has been a major component in the overall reduction in vaccine preventable ...
Sina Ogholikhan, Kathleen B. Schwarz
doaj +3 more sources
Hepatitis B vaccine development and implementation
Human Vaccines and Immunotherapeutics, 2020 Vaccination against hepatitis B is the most effective strategy to control HBV infection. The first licensed hepatitis B vaccine was developed by the purification of hepatitis B surface antigen (HBsAg) from plasma of asymptomatic HBsAg carriers. Then, the
Hong Zhao, Xiaoying Zhou, Yi-Hua Zhou
exaly +2 more sources
Uptake of the Hepatitis B Vaccine Among Pre‐Service Health Professionals in Rwanda [PDF]
Public Health ChallengesBackground High hepatitis B vaccine uptake has led to significant reductions in hepatitis B infection rates and associated health burdens in many countries.
Bivegete Kenny Ntwari +21 more
doaj +2 more sources
Immunogenicity and safety of hepatitis A vaccine at different vaccination intervals among adults aged 18 years and above: Interim results [PDF]
Human Vaccines & ImmunotherapeuticsThis study aims to evaluate the immunogenicity and safety of hepatitis A vaccine administered with one or two doses among adults. Participants aged 18 y and above were recruited, with blood samples collected prior to vaccination for anti-HAV antibodies ...
Lin Chang +13 more
doaj +2 more sources
Hepatitis B Vaccine: Four Decades on [PDF]
VaccinesHepatitis B virus is a substantial contributor to cirrhosis and hepatocellular carcinoma (HCC) globally. Vaccination is the most effective method for prevention of hepatitis B and its associated morbidity and mortality, and the only method to prevent ...
Maria Mironova, Marc G. Ghany
doaj +2 more sources
High confidence and demand for hepatitis E vaccine during an outbreak in Bentiu, South Sudan: A qualitative study. [PDF]
PLOS Global Public HealthIn 2021 in response to an outbreak of hepatitis E in Bentiu internally displaced persons camp the South Sudanese Ministry of Health with support from Médecins Sans Frontières implemented the first-ever mass reactive vaccination campaign with HEV239 ...
Aybüke Koyuncu +17 more
doaj +2 more sources
Contemporary strategy to control viral hepatitis A in the Russian Federation
Журнал микробиологии, эпидемиологии и иммунобиологии, 2021 The problem of choosing a strategy to control hepatitis A in the Russian Federation remains relevant for the health care of our country. By strategy we mean a scientifically based program of action that defines the priorities and resources needed to ...
M. I. Mikhailov, K. K. Kyuregyan
doaj +1 more source
The Journal of Infectious Diseases, 2021 Abstract Hepatitis B is caused by the hepatitis B virus (HBV), which infects the liver and may lead to chronic liver disease, including cirrhosis and hepatocellular carcinoma. HBV represents a worldwide public health problem, causing major morbidity and mortality.
Pattyn, Jade +3 more
openaire +3 more sources
Nigerian Journal of Medicine, 2022 Background: Hepatitis B is a life-threatening viral infection that causes acute and chronic diseases of the liver. Hepatitis B infection is endemic in Nigeria with a national pooled prevalence rate of 9.5%.
Olusegun Elijah Elegbede +3 more
doaj +1 more source
Review of long term immunogenicity and tolerability of live hepatitis A vaccine
Human Vaccines & Immunotherapeutics, 2020 Hepatitis A represents one of the major public health problems worldwide including India. Vaccination is the most effective way to prevent hepatitis A infection.
Nitin Shah +6 more
doaj +1 more source